Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer: Michel Vounatsos

PerkinElmer has appointed Michel Vounatsos to its board of directors, effective March 1. He is currently CEO of Biogen. Before that, he was at Merck, where he held several leadership positions, including president of the Primary Care Customer Business Line and Merck Customer Centricity. Earlier in his career, he held management positions at Ciba-Geigy. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.